Mishcon de Reya page structure
Site header
Main menu
Main content section

Inside Life Sciences

Issue 13: April 2021

Inside Life Sciences

Editor's Note

Welcome to the Spring edition of Inside Life Sciences.


Lundbeck 'pay for delay' case: CJEU judgment

As anticipated, the CJEU has upheld the General Court's judgment that patent settlement agreements between Lundbeck and several generic manufacturers were a restriction of competition by object.


FSA publishes list of just three permitted CBD companies

The Food Standards Agency (FSA) has published its list of the CBD products which can lawfully remain on sale to consumers pending the FSA's formal authorisation. The list contains 22 products only, from just three CBD companies.


New Investment for Life Sciences in the UK

With the life sciences sector contributing more than £70bn per year to the UK economy, the UK Government has proposed a new public/private investment fund into the sector.

Previous Issues

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

I'm a client

I'm looking for advice

Something else